Now showing items 1-1 of 1

    • Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function 

      Lima, Nátalia da Silva; Fernández Fondevila; Nóvoa Deaño, Eva María; Buqué, Xabier; Mercado Gómez, María; Gallet, Sarah; González Rellán, María Jesús; Fernández Paz, Uxía; Loyens, Anne; García Vence, María; Chantada Vázquez, María del Pilar; Bravo López, Susana Belén; Marañón Barnusell, Patricia; Senra Viñas, Ana; Escudero Pérez, Adriana; Leiva Arjona, Magdalena; Guallar Artal, Diana; Fidalgo Pérez, Miguel Ángel; Gomes, Pedro; Claret, Marc; Sabio Buzo, Guadalupe; Varela Rey, Marta; Cardoso Delgado, Teresa; MONTERO VALLEJO, ROCIO; Ampuero, Javier; López Pérez, Miguel Antonio; Diéguez González, Carlos; Herrero, Laura; Serra Cucurull, Dolors; Schwaninger, Markus; Prevot, Vincent; Gallego-Durán, Rocío; Romero-Gómez, Manuel; IRUZUBIETA, PAULA; Crespo García, Javier; Martinez Chantar, Maria Luz; García Monzón, Carmelo; González-Rodríguez, Águeda; Aspichueta, Patricia; Nogueiras Pozo, Rubén (Elsevier, 2021)
      Non-alcoholic fatty liver disease (NAFLD) is a major health threat in both developed and developing countries and is a precursor of the more advanced liver diseases, including non-alcoholic steatohepatitis (NASH), cirrhosis, ...





      Harvesters:Useful links:
      Universidade de Santiago de Compostela | Teléfonos: +34 881 811 000 e +34 982 820 000 | Contact Us | Send Feedback